Correction to: A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
作者信息
Chen Shanshan, Huang Haijun, Huang Wei
机构信息
Department of Infectious Disease, Zhejiang Provincial People's Hospital, Hangzhou, 310014, Zhejiang, China.
Graduate School of Clinical Medicine, Bengbu Medical College, Bengbu, 233000, Anhui, China.
出版信息
BMC Gastroenterol. 2021 Mar 5;21(1):109. doi: 10.1186/s12876-021-01649-0.
Abstract
摘要
相似文献
1
Correction to: A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.《慢性乙型肝炎患者丙氨酸氨基转移酶<2倍正常上限时用于指导抗病毒治疗决策的肝脏组织学无创预测模型》的更正说明
BMC Gastroenterol. 2021 Mar 5;21(1):109. doi: 10.1186/s12876-021-01649-0.
2
Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.慢性乙型肝炎患者丙氨酸氨基转移酶（ALT）小于 2 倍正常值上限时的抗病毒治疗决策的临床非侵入性标志物。
J Viral Hepat. 2019 Feb;26(2):287-296. doi: 10.1111/jvh.13030. Epub 2018 Nov 19.
3
A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.一种用于预测丙氨酸氨基转移酶≤2倍正常上限的HBeAg阳性慢性乙型肝炎患者肝脏组织学的非侵入性模型。
J Gastroenterol Hepatol. 2017 Jan;32(1):215-220. doi: 10.1111/jgh.13452.
4
A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.一种用于预测丙氨酸氨基转移酶≤2倍正常上限的HBeAg阴性慢性乙型肝炎抗病毒治疗的模型。
Liver Int. 2014 Aug;34(7):e229-37. doi: 10.1111/liv.12344. Epub 2013 Oct 23.
5
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中，FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.
6
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.丙氨酸氨基转移酶水平正常或接近正常的慢性丙型肝炎患者：干扰素α-2b治疗的作用
J Hepatol. 1995 Nov;23(5):503-8. doi: 10.1016/0168-8278(95)80054-9.
7
Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.乙肝核心抗体和肝硬度测量可预测 HBeAg 阳性慢性乙型肝炎患者（ALT 水平轻度升高）的 HBeAg 血清学转换。
Clin Exp Med. 2020 May;20(2):241-248. doi: 10.1007/s10238-019-00603-5. Epub 2020 Feb 12.
8
Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.基于影像学的瞬时弹性成像技术评估慢性乙型肝炎患者的显著纤维化：初步研究。
World J Gastroenterol. 2019 Jul 7;25(25):3256-3267. doi: 10.3748/wjg.v25.i25.3256.
9
Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.乙型肝炎 e 抗原阳性的慢性乙型肝炎患者的肝纤维化进展：一项配对瞬时弹性成像检查的前瞻性队列研究。
J Gastroenterol Hepatol. 2013 Nov;28(11):1762-9. doi: 10.1111/jgh.12312.
10
A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.一种用于预测 HBeAg 阳性、丙氨酸氨基转移酶水平正常或轻度升高的乙型肝炎患者肝纤维化的无创评分。
Dis Markers. 2018 Oct 14;2018:3924732. doi: 10.1155/2018/3924732. eCollection 2018.
本文引用的文献
1
A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.一种用于预测慢性乙型肝炎患者肝组织学的非侵入性模型，该模型适用于丙氨酸氨基转移酶（ALT）< 正常值上限 2 倍的抗病毒治疗决策。
BMC Gastroenterol. 2021 Jan 6;21(1):4. doi: 10.1186/s12876-020-01576-6.
Zotero 插件